Goldman Sachs’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Buy |
727,504
+31,497
| +5% | +$641K | ﹤0.01% | 1979 |
|
|
2025
Q1 | $12.6M | Sell |
696,007
-506,446
| -42% | -$9.19M | ﹤0.01% | 2052 |
|
|
2024
Q4 | $30.4M | Sell |
1,202,453
-633,390
| -35% | -$16M | ﹤0.01% | 1447 |
|
|
2024
Q3 | $62.4M | Buy |
1,835,843
+961,650
| +110% | +$32.7M | 0.01% | 921 |
|
|
2024
Q2 | $32.4M | Buy |
874,193
+309,390
| +55% | +$11.5M | 0.01% | 1249 |
|
|
2024
Q1 | $23.7M | Buy |
564,803
+127,044
| +29% | +$5.33M | ﹤0.01% | 1425 |
|
|
2023
Q4 | $17.4M | Buy |
437,759
+25,925
| +6% | +$1.03M | ﹤0.01% | 1671 |
|
|
2023
Q3 | $11.3M | Sell |
411,834
-31,066
| -7% | -$855K | ﹤0.01% | 1897 |
|
|
2023
Q2 | $15M | Buy |
442,900
+82,727
| +23% | +$2.81M | ﹤0.01% | 1756 |
|
|
2023
Q1 | $13M | Sell |
360,173
-89,411
| -20% | -$3.22M | ﹤0.01% | 1820 |
|
|
2022
Q4 | $20M | Sell |
449,584
-214,847
| -32% | -$9.58M | ﹤0.01% | 1625 |
|
|
2022
Q3 | $18.7M | Buy |
664,431
+224,719
| +51% | +$6.32M | ﹤0.01% | 1649 |
|
|
2022
Q2 | $11.9M | Buy |
439,712
+136,293
| +45% | +$3.67M | ﹤0.01% | 1987 |
|
|
2022
Q1 | $10.3M | Buy |
303,419
+49,205
| +19% | +$1.68M | ﹤0.01% | 2214 |
|
|
2021
Q4 | $9.82M | Sell |
254,214
-53,465
| -17% | -$2.07M | ﹤0.01% | 2290 |
|
|
2021
Q3 | $16.6M | Sell |
307,679
-30,376
| -9% | -$1.64M | ﹤0.01% | 1888 |
|
|
2021
Q2 | $11.3M | Sell |
338,055
-130,826
| -28% | -$4.37M | ﹤0.01% | 2163 |
|
|
2021
Q1 | $9.66M | Sell |
468,881
-173,422
| -27% | -$3.57M | ﹤0.01% | 2228 |
|
|
2020
Q4 | $11.3M | Buy |
642,303
+539,046
| +522% | +$9.44M | ﹤0.01% | 1979 |
|
|
2020
Q3 | $1.53M | Buy |
+103,257
| New | +$1.53M | ﹤0.01% | 3058 |
|
|
2019
Q1 | – | Sell |
-3,369
| Closed | -$10K | – | 4180 |
|
|
2018
Q4 | $10K | Sell |
3,369
-31,797
| -90% | -$94.4K | ﹤0.01% | 4049 |
|
|
2018
Q3 | $238K | Sell |
35,166
-98,389
| -74% | -$666K | ﹤0.01% | 3748 |
|
|
2018
Q2 | $1.01M | Buy |
133,555
+102,778
| +334% | +$776K | ﹤0.01% | 3193 |
|
|
2018
Q1 | $1.08M | Buy |
30,777
+11,413
| +59% | +$399K | ﹤0.01% | 3158 |
|
|
2017
Q4 | $825K | Sell |
19,364
-6,096
| -24% | -$260K | ﹤0.01% | 3232 |
|
|
2017
Q3 | $1.09M | Buy |
25,460
+10,957
| +76% | +$470K | ﹤0.01% | 3177 |
|
|
2017
Q2 | $537K | Sell |
14,503
-4,192
| -22% | -$155K | ﹤0.01% | 3502 |
|
|
2017
Q1 | $1.01M | Buy |
18,695
+164
| +0.9% | +$8.88K | ﹤0.01% | 3102 |
|
|
2016
Q4 | $984K | Buy |
18,531
+4,369
| +31% | +$232K | ﹤0.01% | 3100 |
|
|
2016
Q3 | $858K | Sell |
14,162
-14,590
| -51% | -$884K | ﹤0.01% | 3145 |
|
|
2016
Q2 | $1.89M | Sell |
28,752
-1,279
| -4% | -$84.2K | ﹤0.01% | 2635 |
|
|
2016
Q1 | $1.7M | Buy |
30,031
+10,073
| +50% | +$571K | ﹤0.01% | 2608 |
|
|
2015
Q4 | $4.69M | Buy |
19,958
+3,015
| +18% | +$709K | ﹤0.01% | 2080 |
|
|
2015
Q3 | $2.68M | Sell |
16,943
-8,393
| -33% | -$1.33M | ﹤0.01% | 2370 |
|
|
2015
Q2 | $9.58M | Buy |
25,336
+4,486
| +22% | +$1.7M | ﹤0.01% | 1711 |
|
|
2015
Q1 | $8.72M | Sell |
20,850
-1,722
| -8% | -$720K | ﹤0.01% | 1739 |
|
|
2014
Q4 | $6.18M | Buy |
22,572
+5,606
| +33% | +$1.53M | ﹤0.01% | 1859 |
|
|
2014
Q3 | $3.3M | Buy |
16,966
+2,077
| +14% | +$404K | ﹤0.01% | 2223 |
|
|
2014
Q2 | $3.65M | Sell |
14,889
-559
| -4% | -$137K | ﹤0.01% | 2189 |
|
|
2014
Q1 | $4.09M | Buy |
15,448
+715
| +5% | +$189K | ﹤0.01% | 2122 |
|
|
2013
Q4 | $5.35M | Buy |
14,733
+1,923
| +15% | +$698K | ﹤0.01% | 1949 |
|
|
2013
Q3 | $6.81M | Buy |
12,810
+4,317
| +51% | +$2.29M | ﹤0.01% | 1711 |
|
|
2013
Q2 | $1.99M | Buy |
+8,493
| New | +$1.99M | ﹤0.01% | 2383 |
|